AMEXInformation TechnologySoftware - ApplicationSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for INLX yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
successful execution of CEO transition and strategy | A primary condition in Intellinetics Inc's published investment case. The stated target is clear progress on turnaround milestones by end of 2026. | Under Pressure | no meaningful progress or worsening results by end of 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 7–Nov 5 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 12, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk turnaround-style thesis, not a proven durable compounder. Its current state is watch: recent performance is weak, the long-term thesis has not freshly broken, and confidence has eased to medium.
The valuation model describes INLX as cheap versus peers, while also showing a 29% premium versus peers; model confidence is low. The expectations gap is negative, which suggests expectations remain difficult to meet, but the evidence does not show that the business is priced for a clear recovery.
Near term, revenue delivery remains weak: total revenue fell year over year in both recent quarters, while SaaS growth improved from 0.1% to 4.2% but remains below management’s double-digit fiscal 2026 goal. Management has emphasized execution, operational discipline, and product investment, but measurable progress is limited; a guidance cut on the next call would be a meaningful risk.
The multi-year thesis depends on SaaS growth accelerating and improved sales execution translating into stronger revenue. Near term, a guidance cut could reinforce the weak trend, while easier rates or steadier results and guidance from major technology peers could ease sector pressure.
Over the next 1 to 3 years, INLX remains an uncertain turnaround thesis with high risk and limited proof that management priorities are producing stronger results. The central question is whether SaaS growth and revenue execution improve enough to support the stated goals. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in Intellinetics Inc's published investment case. The stated target is reduce losses and improve free cash flow by at least 50% in FY26. |
| Broken |
| losses widen or free cash flow remains near zero or negative in FY26 |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
double-digit year-over-year SaaS revenue growth | The company targets double-digit SaaS growth in fiscal 2026. | Broken | SaaS revenue growth falls below 5% YoY in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: “SaaS revenue increased 4.2% year over year in Q2, and we continue to expect double-digit year-over-year SaaS growth for fiscal 2026.” “As the Company enters the second half of 2026, management is focused on converting software opportunities into recurring revenue, improving go-to-market execution, and prioritizing product and technology investments that support a more scalable business model.” Delivery assessment Nov 5, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.